Copyright investors
When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Omada Health (OMDA) now meets that criteria, with an increase from 80 to 83 Tuesday. This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database. Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an RS Rating north of 80 as they launch their biggest price moves. Omada Health is not currently showing a potential buy point. See if the stock goes on to form a chart pattern that could launch a new move. The company showed 0% EPS growth in the latest quarterly report. Revenue rose 49%. Look for the next report on or around Nov. 6. The company earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings (WGS), InfuSystem Holdings (INFU) and GRAIL (GRAL) are among the top 5 highly rated stocks within the group. This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
